tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market

Kalaris Therapeutics (KLRS) Similar Stocks

Compare
366 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kalaris Therapeutics
$8.50
$148.46M
-1.15
-18.27%
2 Buy
0 Hold
0 Sell
Moderate Buy
Coherus Biosciences
$1.39
$163.18M
-0.88
-18.24%
3 Buy
0 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$53.30
$1.11B
-6.72
255.33%
7 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.90
$348.22M
176.88%
1 Buy
2 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$18.52
$153.25M
26.19
-10.67%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kodiak Sciences
$23.02
$1.26B
-5.59
183.50%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KLRS
Kalaris Therapeutics
8.50
-2.01
-19.12%
CHRS
Coherus Biosciences
1.39
-0.32
-18.71%
NKTR
Nektar Therapeutics
53.30
38.00
248.37%
CLLS
Cellectis SA
4.79
3.09
181.76%
MCRB
Seres Therapeutics
15.90
-1.70
-9.66%
KOD
Kodiak Sciences
23.02
14.15
159.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts